IL7 and neoplasm: In another strategy, IL-7-loaded oncolytic adenoviruses (oAD-IL7) were used in vivo to improve the effectiveness of B7H3-CAR-T cell therapy by enhancing T cell persistence, which led to prolonged survival of the GBM tumor-bearing mice.